These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4142098)

  • 21. [Liver function in porphyria cutanea tarda. Experiences with 32 patients].
    Pietschmann H; Raab W; Hartl O
    Wien Z Inn Med; 1966 Sep; 47(9):349-62. PubMed ID: 4187166
    [No Abstract]   [Full Text] [Related]  

  • 22. A contribution to early diagnosis of primary hepatic cell carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 May; 7(3):397-411. PubMed ID: 6181578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of blood biochemical liver function tests in asymptomatic chronic HBs Ag carriers.
    Iwamura K; Okada T
    Tokai J Exp Clin Med; 1982 Mar; 7(2):295-303. PubMed ID: 6179263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Indicators of nonspecific immunity in cirrhosis and primary cancer of the liver].
    Afanas'eva KA; Afanas'ev SS; Ablaeva TD; Podobedov GM
    Vopr Onkol; 1976; 22(12):21-4. PubMed ID: 1020251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic investigations and other ndices of liver function in cirrhosis.
    Drozdz H; Jedrychowdki A; Mysik M
    Pol Med Sci Hist Bull; 1971 Jul; 14(3):127-31. PubMed ID: 5571798
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prognostic significance of transitory alpha 1 fetoprotein increases in liver cirrhosis].
    Lehmann FG
    Z Gastroenterol Verh; 1976; (11):55-61. PubMed ID: 65864
    [No Abstract]   [Full Text] [Related]  

  • 27. [A liver-specific antigen in the serum of patients with liver disease].
    Rosenmund A
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1023-6. PubMed ID: 5003908
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathological anatomy of liver cancer. (Review of autopsy and biopsy material)].
    Enríquez L; Ferrer R; Schwarz A
    Rev Clin Esp; 1970 Nov; 119(3):217-24. PubMed ID: 5495926
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gamma-glutamyltransferase and alkaline phosphatase in the serum and saliva of patients with hepatic tumors and hepatic cirrhosis].
    Jiménez-Alonso J; Jaimez L; Barrios L; Pérez-Jiménez F; García A; Bejarano R; Ogea JL; Jiménez-Pereperez JA
    Rev Esp Oncol; 1984; 31(2):315-9. PubMed ID: 6152769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in hepatic blood flow and blood volume after splenectomy for bilharzial hepatosplenic fibrosis.
    Nofal MM; Hidayat MA; Mahran AA; Haxton JA
    J Trop Med Hyg; 1972 Apr; 75(4):80-4. PubMed ID: 5031861
    [No Abstract]   [Full Text] [Related]  

  • 31. Laparoscopic contribution to liver tumour diagnosis.
    Banciu T; Prodan P
    Med Interne; 1984; 22(3):217-9. PubMed ID: 6238398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative evaluation of immunoglobulins in the serum of patients with hepatic cirrhosis.
    Mamont B; Eberhardt A
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):190-4. PubMed ID: 4192696
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
    Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
    J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical diagnosis of alcoholic fatty liver.
    Devenyi P; Rutherdale J; Sereny G; Olin JS
    Am J Gastroenterol; 1970 Dec; 54(6):597-602. PubMed ID: 5504217
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic trial with methylphenobarbital (Prominal), an enzyme inducer, in liver disease. A contribution to the question of hepatotoxicity of barbiturates.
    Glogner P; Massarrat S; Henrichs HR
    Acta Hepatosplenol; 1971; 18(5):394-7. PubMed ID: 5112056
    [No Abstract]   [Full Text] [Related]  

  • 36. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunosuppresive treatment in chronic hepatitis and liver cirrhosis].
    Evers C; Hesch RD; Banzer D
    Med Welt; 1969 Feb; 8():415-21. PubMed ID: 4181608
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the clinical evaluation of enzyme activity in blood serum during liver cirrhosis].
    Usov DV; Khokhlova VI
    Klin Med (Mosk); 1967 Mar; 45(3):72-6. PubMed ID: 5604374
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.